TY - JOUR
T1 - Recent advances in self-assembled nanoparticles for drug delivery
AU - Verma, Lanke Tejesh
AU - Singh, Nidhi
AU - Gorain, Bapi
AU - Choudhury, Hira
AU - Tambuwala, Murtaza M.
AU - Kesharwani, Prashant
AU - Shukla, Rahul
PY - 2020/2/10
Y1 - 2020/2/10
N2 - The collection of different bulk materials forms the nanoparticles, where the properties of the nanoparticle are solely different from the individual components before being ensembled. Self-assembled nanoparticles are basically a group of complex functional units that are formed by gathering the individual bulk components of the system. It includes micelles, polymeric nanoparticle, carbon nano-tubes, liposomes and niosomes, etc. This self-assembly has progressively heightened interest to control the final complex structure of the nanoparticle and its associated properties. The main challenge of for-mulating self-assembled nanoparticle is to improve the delivery system, bioavailability, enhance circulation time, confer molecular targeting, controlled release, protection of the incorporated drug from exter-nal environment and also serve as nanocarriers for macromolecules. Ultimately, these self-assembled nanoparticles facilitate to overcome the physiological barriers in vivo. Self-assembly is an equilibrium process where both individual and assembled components are subsisting in equilibrium. It is a bottom up approach in which molecules are assembled spontaneously, non-covalently into a stable and well-defined structure. There are different approaches that have been adopted in fabrication of self-assembled nanoparticles by the researchers. The current review is enriched with strategies for nanoparticle self-assembly, associated properties, and its application in therapy.
AB - The collection of different bulk materials forms the nanoparticles, where the properties of the nanoparticle are solely different from the individual components before being ensembled. Self-assembled nanoparticles are basically a group of complex functional units that are formed by gathering the individual bulk components of the system. It includes micelles, polymeric nanoparticle, carbon nano-tubes, liposomes and niosomes, etc. This self-assembly has progressively heightened interest to control the final complex structure of the nanoparticle and its associated properties. The main challenge of for-mulating self-assembled nanoparticle is to improve the delivery system, bioavailability, enhance circulation time, confer molecular targeting, controlled release, protection of the incorporated drug from exter-nal environment and also serve as nanocarriers for macromolecules. Ultimately, these self-assembled nanoparticles facilitate to overcome the physiological barriers in vivo. Self-assembly is an equilibrium process where both individual and assembled components are subsisting in equilibrium. It is a bottom up approach in which molecules are assembled spontaneously, non-covalently into a stable and well-defined structure. There are different approaches that have been adopted in fabrication of self-assembled nanoparticles by the researchers. The current review is enriched with strategies for nanoparticle self-assembly, associated properties, and its application in therapy.
KW - Driving forces
KW - Gold nanoparticle
KW - Liposome
KW - Mesoporous silica nanoparticle
KW - Nanoparticle
KW - Self-assembly
UR - https://pubmed.ncbi.nlm.nih.gov/32039683/
UR - http://www.scopus.com/inward/record.url?scp=85080041148&partnerID=8YFLogxK
U2 - 10.2174/1567201817666200210122340
DO - 10.2174/1567201817666200210122340
M3 - Review article
C2 - 32039683
SN - 1567-2018
VL - 17
SP - 279
EP - 291
JO - Current Drug Delivery
JF - Current Drug Delivery
IS - 4
ER -